Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kaposi's sarcoma and AIDS: a variable spectrum.

F A Shepherd1, S Hogg-Johnson, N Fleshner

  • 1Department of Medicine, Toronto General Hospital, Ontario.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|December 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel germline genetic variants associated with venous thrombo-embolism (VTE) and arterial thrombo-embolism (ATE) risk in patients with ALK and ROS1 fusion non-small cell lung cancer (NSCLC).

Thrombosis research·2026
Same author

Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort.

Lung cancer (Amsterdam, Netherlands)·2024
Same author

Abstracts of presentations to the Annual Meetings of the Canadian Society of Colon and Rectal Surgeons Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons: Canadian Surgery Forum, Toronto, Ont., September 6-9, 2007.

Canadian journal of surgery. Journal canadien de chirurgie·2023
Same author

Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment.

Current oncology (Toronto, Ont.)·2020
Same author

Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.

Current oncology (Toronto, Ont.)·2020
Same journal

Newsletter Spring 2026: Clinician Investigator Trainee Association of Canada (CITAC).

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

A study of suicide risk and prognostic characteristics in patients with osteosarcoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

The expression and mechanism of action of MicroRNA-210 in preeclampsia.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
See all related articles

This study identified key prognostic factors for Kaposi

Area of Science:

  • Oncology
  • Immunology
  • Epidemiology

Background:

  • Kaposi's sarcoma (KS) is an AIDS-defining illness.
  • Prognostic factors for KS in AIDS patients require further elucidation.
  • Understanding survival predictors is crucial for managing patients with KS and AIDS.

Purpose of the Study:

  • To identify prognostic variables in a cohort of male patients with Kaposi's sarcoma and AIDS.
  • To analyze the relationship between clinical and laboratory parameters and patient survival.
  • To evaluate the impact of opportunistic infections and systemic symptoms on survival.

Main Methods:

  • Retrospective analysis of 61 male patients with Kaposi's sarcoma and AIDS.
  • Kaplan-Meier estimates and Cox Regression Model were used for survival analysis.

Related Experiment Videos

  • Examination of clinical staging, opportunistic infections, systemic symptoms, and laboratory parameters.

    • Main Results:

    • Median overall survival was 10.5 months.
    • Patients with both systemic symptoms and minor opportunistic infections had significantly shorter survival (p = 0.03).
    • Hemoglobin, absolute lymphocyte count, platelet count, and T4 level were significant predictors of survival.

    Conclusions:

    • Systemic symptoms and opportunistic infections significantly impact survival in AIDS-related Kaposi's sarcoma.
    • Specific laboratory parameters are crucial indicators for predicting survival.
    • Further research into treatment strategies and prognostic markers is warranted.